Loading...
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
AIMS: We investigated clinical characteristics and outcomes of patients with significant valvular disease (SVD) in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) trial. METH...
Na minha lista:
| Udgivet i: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4265383/ https://ncbi.nlm.nih.gov/pubmed/25148838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu305 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|